Developer of a science illustration software designed to empower the world to learn and communicate science through visuals. The company's platform permits scientists to create their compositions without any drawing, export their custom images in their preferred format and showcase their research, enabling scientists to quickly and easily communicate their research.
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Developer of visual illustration software designed to create digital products. The company's product offers services in line with software development, interfaces, branding, augmented reality (AR) and virtual reality (VR) development for web and mobile experience design, 3D animation, motion design and video, illustration, and visual content, custom software development enabling businesses and corporate clients to acquire customized digital user experiences and convert their dreams into digital realities.
Developer of a research platform designed to automate and improve administrative tasks throughout the research life-cycle. The company's platform leverages artificial intelligence to offer real-time data capture and reporting, compliance and security, automated document creation and filing, customization and branding, enabling medical researchers to streamline clinical operations and patient engagement easily.